In-111 pentetreotide scintigraphy in patients with neuroblastoma: Comparison with I-131 MIBG, N-myc oncogene amplification, and patient outcome

Clinical Nuclear Medicine

Volumn 22, Issue 5, 1997, Pages 315-319

  Shalaby Rana, Eglal ^a   Majd, Massoud ^a,c   Andrich, Mary P ^a   Movassaghi, Nasser ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

I 131 MIBG; In 111 Pentetreotide; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; MEDRONATE TECHNETIUM TC 99M; PENTETREOTIDE IN 111;

ARTICLE; BONE MARROW BIOPSY; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; GENE AMPLIFICATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; ONCOGENE C MYB; PROGNOSIS; WHOLE BODY SCINTISCANNING;

3-IODOBENZYLGUANIDINE; BONE NEOPLASMS; CAUSE OF DEATH; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GANGLIONEUROBLASTOMA; GENE AMPLIFICATION; GENES, MYC; HUMANS; INDIUM RADIOISOTOPES; INFANT; IODINE RADIOISOTOPES; IODOBENZENES; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0030974141     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199705000-00008     Document Type: Article

References (11)

1. Maggi M, Baldi E, Finetti G, et al: Identification, characterization and biological activity of somatostatin receptors in human neuroblastoma cell lines. Can Res 54:124, 1994.
2. O'Dorisio MS, Chen F, O'Dorisio TM, et al: of Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ 5:1, 1994.
3. O'Dorisio MS, Hauger M, Cecalupo AJ: Somatostatin receptors in neuroblastoma: Diagnostic and therapeutic implications. Semin Oncol 21:33, 1994 (Supplement 13).
4. Moertel CL, Reubi J, Scheithauer BS, et al: Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 102:752, 1994.
5. Sautter-Bihl M, Dorr U, Schilling F, et al: Somatostatin receptor imaging: A new horizon in the diagnostic management of neuroblastoma. Semin Oncol 21:38, 1994 (Supplement 13).
6. Krenning EP, Kwekkeboom DJ, Bakker WH, et al: Somatostatin receptor scintigraphy with (111In-DTPA-D-Pne1) and (123I-Tyr3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716, 1993.
7. Lauriero F, Rubini G, D'Addabbo F, et al: I-131 MIBG scintigraphy of neuroectodermal tumors. Comparison between I-131MIBG and In-111 DTPA-octreotide. Clin Nuc Med 20: 243, 1995.
8. Manil L, Edeline V, Lumbroso J, et al: Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med 37:893, 1996.
9. Bakker WH, Albert R, Bruns C, et al: 111-In-DTPA-D-Phe-1octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and invitro validation. Life Sci 49:1583, 1991.
10. Bakker WH, Krenning EP, Breeman WA, et al: Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. J Nucl Med 31:1501, 1990.
11. Bakker WH, Krenning EP, Reubi J-C, et al: In vivo application of (111-In-DTPA-D-Phe1)-octreotide for detection of somatostatin receptor-positive tumours in rats. Life Sci 49:1593, 1991.